317 related articles for article (PubMed ID: 18612991)
1. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G
Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991
[TBL] [Abstract][Full Text] [Related]
2. Detection of low-frequency human antigen-specific CD4(+) T cells using MHC class II multimer bead sorting and immunoscope analysis.
Lemaître F; Viguier M; Cho MS; Fourneau JM; Maillère B; Kourilsky P; Van Endert PM; Ferradini L
Eur J Immunol; 2004 Oct; 34(10):2941-9. PubMed ID: 15368300
[TBL] [Abstract][Full Text] [Related]
3. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
4. The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.
Cecconi V; Moro M; Del Mare S; Sidney J; Bachi A; Longhi R; Sette A; Protti MP; Dellabona P; Casorati G
Eur J Immunol; 2010 Jun; 40(6):1603-16. PubMed ID: 20306469
[TBL] [Abstract][Full Text] [Related]
5. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
6. MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete.
Mallone R; Nepom GT
Clin Immunol; 2004 Mar; 110(3):232-42. PubMed ID: 15047201
[TBL] [Abstract][Full Text] [Related]
7. Multiplex mapping of CD4 T cell epitopes using class II tetramers.
Yang J; James EA; Huston L; Danke NA; Liu AW; Kwok WW
Clin Immunol; 2006 Jul; 120(1):21-32. PubMed ID: 16677863
[TBL] [Abstract][Full Text] [Related]
8. Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⁺ T cells.
Bonvalet M; Wambre E; Moussu H; Horiot S; Kwok WW; Louise A; Ebo D; Hoarau C; Van Overtvelt L; Baron-Bodo V; Moingeon P
Clin Exp Allergy; 2011 Jun; 41(6):821-9. PubMed ID: 21418343
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
10. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
[TBL] [Abstract][Full Text] [Related]
12. Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects.
Wambre E; Van Overtvelt L; Maillère B; Humphreys R; von Hofe E; Ferhat L; Ebo D; Moingeon P
Int Arch Allergy Immunol; 2008; 146(2):99-112. PubMed ID: 18204276
[TBL] [Abstract][Full Text] [Related]
13. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
14. HLA class II peptide tetramers vs allergen-induced proliferation for identification of allergen-specific CD4 T cells.
Van Hemelen D; Mahler V; Fischer G; Fae I; Reichl-Leb V; Pickl W; Jutel M; Smolinska S; Ebner C; Bohle B; Jahn-Schmid B
Allergy; 2015 Jan; 70(1):49-58. PubMed ID: 25236500
[TBL] [Abstract][Full Text] [Related]
15. Effector and regulatory T cells derived from the same T cell clone differ in MHC class II-peptide multimer binding.
Nolte-'t Hoen EN; Amoroso MG; Veenstra J; Grosfeld-Stulemeyer MC; van Eden W; Broeren CP; Wauben MH
Eur J Immunol; 2004 Dec; 34(12):3359-69. PubMed ID: 15549773
[TBL] [Abstract][Full Text] [Related]
16. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
18. Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers.
Xu M; Lu X; Sposato M; Zinckgraf JW; Wu S; von Hofe E
Vaccine; 2009 Jul; 27(34):4641-7. PubMed ID: 19520206
[TBL] [Abstract][Full Text] [Related]
19. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
Thompson JA; Dissanayake SK; Ksander BR; Knutson KL; Disis ML; Ostrand-Rosenberg S
Cancer Res; 2006 Jan; 66(2):1147-54. PubMed ID: 16424052
[TBL] [Abstract][Full Text] [Related]
20. MHC II and the endocytic pathway: regulation by invariant chain.
Landsverk OJ; Bakke O; Gregers TF
Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
